Cargando…
The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients
BACKGROUND: As the incidence of prostate cancer continues to rise steeply, there is an increasing need to identify more accurate prognostic markers for the disease. There is some evidence that a higher modified Glasgow Prognostic Score (mGPS) may be associated with poorer survival in patients with p...
Autores principales: | Shafique, Kashif, Proctor, Michael J, McMillan, Donald C, Leung, Hing, Smith, Karen, Sloan, Billy, Morrison, David S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686580/ https://www.ncbi.nlm.nih.gov/pubmed/23768149 http://dx.doi.org/10.1186/1471-2407-13-292 |
Ejemplares similares
-
Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study
por: Proctor, Michael J., et al.
Publicado: (2015) -
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011) -
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2010) -
Coffee consumption and prostate cancer risk: further evidence for inverse relationship
por: Shafique, Kashif, et al.
Publicado: (2012) -
Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up
por: Shafique, Kashif, et al.
Publicado: (2012)